Maybio Matrix
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- Undisclosed
Investors
- 6
About Maybio Matrix
Established in 2019 and based in Beijing, China, Maybio Matrix operates as a pharmaceutical biotechnology company that focuses on the research and development of new materials for regenerating human extracellular matrix. It has a branch in Hunan. Dr. E Xiao, the company's co-founder and chairman, graduated from the University of Pennsylvania. In 2022, the company won the "VB-Find Award for the Top 100 Most Innovative Medical Technology Products (Solutions)". It cooperates with Central South University, Hunan University, Sichuan University, and Nanjing University., LTD. The company provides regenerative bioscaffold materials for maxillofacial defects and deformity repair in the field of medical aesthetics. It uses human extracellular matrix (ECM) technology to establish a sterile processing production line for prefilled needles. Products are divided into Meiweiti-Ya, Yao, and Nuo series products. Products include collagen hydrating, film-forming excipients, hydrating solutions, collagen gels, collagen freeze-dried fibers and other drugs, medical devices, and cosmetics. ECM products also can be used in myocardium, ligaments, joints, and other fields. The company generates revenue by providing new ECM regeneration materials, medical and beauty products, and cosmetics.
Who invested in Maybio Matrix
6 investors across 3 rounds
See all investors in Maybio Matrix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Maybio Matrix
Who invested in Maybio Matrix?
Maybio Matrix has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Maybio Matrix raised?
Maybio Matrix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Maybio Matrix last raise money?
Maybio Matrix's most recent round on record is a Series A, in Sep 2023.
What does Maybio Matrix do?
Established in 2019 and based in Beijing, China, Maybio Matrix operates as a pharmaceutical biotechnology company that focuses on the research and development of new materials for regenerating human extracellular matrix.
Where is Maybio Matrix headquartered?
Maybio Matrix is headquartered in Beijing, China.
Which VCs invest in companies like Maybio Matrix?
Among active investors with capital left to deploy, Hui Hua Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back materials companies at Maybio Matrix's stage. Their profiles are linked below.
VCs backing materials startups at Series A
Raising like Maybio Matrix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.